Zydus Lifesciences Ltd 532321
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- ₹1,163.35
- Day Range
- ₹1,123.35–1,157.95
- 52-Week Range
- ₹835.85–1,232.00
- Bid/Ask
- ₹0.00 / ₹0.00
- Shares Outstanding
- 997.50M
- Market Cap
- ₹1.14T
- Volume/Avg
- 136,802 / 105,401
Key Statistics
- Price/Earnings (Normalized)
- 25.16
- Price/Sales
- 4.11
- Dividend Yield (Trailing)
- 0.09%
- Dividend Yield (Forward)
- 0.09%
- Dividend Payment Schedule
- Aug
- Total Yield
- 0.09%
Company Profile
Zydus Lifesciences Ltd operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products. The product portfolio of the company includes Active Pharmaceutical Ingredients [API] and human formulations. The company's operating segments are: Pharmaceuticals, Consumer Products and Medical Technologies. The majority of revenue is derived from the Pharmaceuticals segment. Geographically, it generates maximum revenue from the United States, followed by India, Europe and other countries.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Core
- Total Number of Employees
- 36,827
- Website
- https://www.zyduslife.com
Valuation
|
Metric
|
532321
|
|---|---|
Price/Earnings (Normalized) | 25.16 |
Price/Book Value | 4.25 |
Price/Sales | 4.11 |
Price/Cash Flow | 26.27 |
Price/Earnings
532321
Financial Strength
|
Metric
|
532321
|
|---|---|
Quick Ratio | 0.67 |
Current Ratio | 1.27 |
Interest Coverage | 12.77 |
Quick Ratio
532321
Profitability
|
Metric
|
532321
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
532321
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|!f^$jg& | LOCK|G@T$q | $67B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|H#>Kmh$ | LOCK|?>L% | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|S$f^>Q? | LOCK|L#^ | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|ygNs?TD | LOCK|j@ | $29B | |||
| Viatris Inc
VTRS
| LOCK|F>%s%D | LOCK|VG | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|!Q | LOCK|Wb | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|$r!S&b^ | LOCK|xh | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|fJ&>!#Z | LOCK|t$& | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|V^NFd& | LOCK|L#<#X | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|yMG@$<% | LOCK|@k | $2B |
United States